ABUS Latest Press Releases

-- October 22, 2026 --

Arbutus Announces FDA Clinical Hold is Lifted on IND Application for AB-101, an Oral PD-L1 Inhibitor Globe Newswire 7:30 AM

-- October 1, 2026 --

Arbutus Announces Final Results of Its US$230 Million Modified 'Dutch Auction' Tender Offer Globe Newswire 7:30 AM

-- September 30, 2026 --

Arbutus Announces Preliminary Results of Its US$230 Million Modified 'Dutch Auction' Tender Offer Globe Newswire 7:30 AM

-- August 24, 2026 --

Arbutus Commences US$230 Million Modified 'Dutch Auction' Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share Globe Newswire 7:30 AM

-- August 21, 2026 --

Arbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified 'Dutch Auction' Tender Offer Globe Newswire 7:30 AM

-- August 12, 2026 --

Arbutus Reports Second Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 7:30 AM

-- July 16, 2026 --

Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders Globe Newswire 7:30 AM

Market Data Delayed 15 Minutes